<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63739">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01879137</url>
  </required_header>
  <id_info>
    <org_study_id>CARGO 2013</org_study_id>
    <nct_id>NCT01879137</nct_id>
  </id_info>
  <brief_title>Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome</brief_title>
  <official_title>Copeptin After Arginine Infusion for the Differential Diagnosis of the Polyuria-Polydipsia Syndrome ''The CARGO-Study''</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <authority>Switzerland: Swissmedic</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      the purpose of the study is to investigate whether arginine infusion is a new tool to
      differentiate patients with diabetes insipidus, primary polydipsia and healthy subjects.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Discriminative value of copeptin after arginine infusion in the differential diagnosis of polyuria-polydipsia syndrome.</measure>
    <time_frame>up to 120 minutes after the Arginine infusion.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Healthy</condition>
  <condition>Polyuria-polydipsia Syndrome</condition>
  <arm_group>
    <arm_group_label>healthy adults</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with a polyuria-polydipsia syndrome</arm_group_label>
  </arm_group>
  <biospec_descr>
    <textblock>
      Serum EDTA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy adults Patients with polyuria-polydipsia syndrome
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age over 18 years

          2. No medication except hormonal contraception

        Exclusion Criteria:

          1. Evidence of any acute illness

          2. Subjects refusing or unable to give written informed consent

          3. Pregnancy

          4. Any evidence of disordered drinking habits and diuresis
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <state>Basel-Stadt</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mirjam Christ-Crain</last_name>
      <phone>061/ 265 25 25</phone>
    </contact>
    <investigator>
      <last_name>Mirjam Christ-Crain</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>May 19, 2014</lastchanged_date>
  <firstreceived_date>June 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Basel, Switzerland</investigator_affiliation>
    <investigator_full_name>Mirjam Christ-Crain</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Copeptin</keyword>
  <keyword>Arginin stimulation test</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Polyuria</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
